Literature DB >> 18566442

Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis.

Katsushi Kurosu1, Yuichi Takiguchi, Osamu Okada, Norio Yumoto, Seiichiro Sakao, Yuji Tada, Yasunori Kasahara, Nobuhiro Tanabe, Koichiro Tatsumi, Michael Weiden, William N Rom, Takayuki Kuriyama.   

Abstract

Consistent with the hypothesis that pulmonary epithelial apoptosis is the key to the acute exacerbation of idiopathic pulmonary fibrosis (IPF), we conducted serological identification of Ags by recombinant expression cloning (SEREX) analysis using type II alveolar cell carcinoma (A549) cell lines to identify disease-related Abs. In a survey of Abs to the recombinant autoantigens identified by SEREX analysis, five Abs were identified as novel candidates for the acute exacerbation of IPF. Abs to annexin 1 were detected in 47 and 53% of the sera and bronchoalveolar lavage materials from patients with acute exacerbation of IPF. Some identical TCR Vbeta genes were identified in sequential materials obtained at 1-3 mo in all 10 acute exacerbation IPF cases, suggesting that some infiltrating CD4-positive T cells sharing limited epitopes expand by Ag-driven stimulation during disease extension. The CDR3 region of these identical TCR Vbeta genes showed high homology with the N-terminal portion of annexin 1, including in the HLA-DR ligand epitopes predicted by TEPITOPE analysis. By Western blotting analysis and observation of the CD4-positive T cell responses in bronchoalveolar lavage samples, the N-terminal portion of annexin 1 was cleaved and found to induce marked proliferative responses of CD4-positive T cells in three patients. Our study demonstrates that annexin 1 is an autoantigen that raises both Ab production and T cell response in patients with acute exacerbation of IPF, and that the N-terminal portion of annexin 1 plays some role in the pathogenesis of acute exacerbation in IPF patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566442     DOI: 10.4049/jimmunol.181.1.756

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 2.  Idiopathic pulmonary fibrosis and a role for autoimmunity.

Authors:  Gerard F Hoyne; Hannah Elliott; Steven E Mutsaers; Cecilia M Prêle
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

3.  Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study.

Authors:  Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson; Tim Bongartz
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

Review 4.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

5.  Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance.

Authors:  Anthony K Shum; Jason DeVoss; Catherine L Tan; Yafei Hou; Kellsey Johannes; Clodagh S O'Gorman; Kirk D Jones; Etienne B Sochett; Lawrence Fong; Mark S Anderson
Journal:  Sci Transl Med       Date:  2009-12-02       Impact factor: 17.956

Review 6.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

7.  Proteomic analysis of radiation-induced changes in rat lung: Modulation by the superoxide dismutase mimetic MnTE-2-PyP(5+).

Authors:  Vasily A Yakovlev; Christopher S Rabender; Heidi Sankala; Ben Gauter-Fleckenstein; Katharina Fleckenstein; Ines Batinic-Haberle; Isabel Jackson; Zeljko Vujaskovic; Mitchell S Anscher; Ross B Mikkelsen; Paul R Graves
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-30       Impact factor: 7.038

8.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Authors:  Syed R Gilani; Louis J Vuga; Kathleen O Lindell; Kevin F Gibson; Jianmin Xue; Naftali Kaminski; Vincent G Valentine; Emily K Lindsay; M Patricia George; Chad Steele; Steven R Duncan
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

9.  Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Authors:  Jianmin Xue; Daniel J Kass; Jessica Bon; Louis Vuga; Jiangning Tan; Eva Csizmadia; Leo Otterbein; Makoto Soejima; Marc C Levesque; Kevin F Gibson; Naftali Kaminski; Joseph M Pilewski; Michael Donahoe; Frank C Sciurba; Steven R Duncan
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

10.  BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Authors:  Anthony K Shum; Mohammad Alimohammadi; Catherine L Tan; Mickie H Cheng; Todd C Metzger; Christopher S Law; Wint Lwin; Jaakko Perheentupa; Helene Bour-Jordan; Jean Claude Carel; Eystein S Husebye; Filippo De Luca; Christer Janson; Ravishankar Sargur; Noémie Dubois; Merja Kajosaari; Paul J Wolters; Harold A Chapman; Olle Kämpe; Mark S Anderson
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.